Patent classifications
B01J2531/46
HIGH-DENSITY ETHYLENE-BASED POLYMER USING SUPPORTED HYBRID METALLOCENE CATALYST, AND MANUFACTURING METHOD THEREFOR
A high-density ethylene-based polymer is provided. The high-density ethylene-based polymer contains an ethylene homopolymer or a copolymer of ethylene and at least one comonomer selected from the group consisting of an -olefin, a cyclic olefin, and a straight, branched and cyclic diene. The high-density polyethylene resin has a wide molecular weight distribution and excellent comonomer distribution characteristics, has excellent melt flowability due to a long chain branched structure, and has excellent mechanical characteristics since the comonomer distribution is concentrated in a high-molecular-weight body. The high-density ethylene polymer has excellent molding processability during processing such as extrusion, compression, injection and rotational molding by having excellent mechanical characteristics and melt flowability.
Use of composition comprising titanium or zirconium alkoxide or aryloxide in aromatic carbonate preparation process
The invention relates to a process for preparing an aromatic carbonate, comprising reacting a dialkyl carbonate or an alkyl aryl carbonate with an aryl alcohol or an alkyl aryl carbonate, resulting in an aromatic carbonate which is an alkyl aryl carbonate or a diaryl carbonate.
Metal organic frameworks, their synthesis and use
A novel metal organic framework, EMM-42, is described having the structure of UiO-66 and comprising bisphosphonate linking ligands. EMM-42 has acid activity and is useful as a catalyst in olefin isomerization. Also disclosed is a process of making metal organic frameworks, such as EMM-42, by heterogeneous ligand exchange, in which linking ligands having a first bonding functionality in a host metal organic framework are exchanged with linking ligands having a second different bonding functionality in the framework.
Modified Catalyst Supports
The invention covers a supported catalyst system prepared according to a process comprising the following step: i). impregnating a silica-containing catalyst support having a specific surface area of from 150 m.sup.2/g to 800 m.sup.2/g, preferably 280 m.sup.2/g to 600 m.sup.2/g, with one or more titanium compounds of the general formula selected from R.sub.nTi(OR).sub.m and (RO).sub.nTi(OR).sub.m, wherein R and R are the same or different and are selected from hydrocarbyl groups containing from 1 to 12 carbon and halogens, and wherein n is 0 to 4, m is 0 to 4 and m+n equals 4, to form a titanated silica-containing catalyst support having a Ti content of at least 0.1 wt % based on the weight of the Ti-impregnated catalyst support
wherein the supported catalyst system further comprises an alumoxane and a metallocene.
Method for manufacturing diarylmethane compound
An object is to provide a method for producing a compound which is useful as a synthetic intermediate for an active pharmaceutical ingredient of an antidiabetic drug or the like in an industrially inexpensive and efficient manner, and the present invention can achieve the object by reducing a compound (2) represented by the following formula (2): ##STR00001## wherein R.sub.1, Ar, n and X are as mentioned herein in the presence of a titanium compound by using a reducing agent to produce a compound (1) represented by the following formula (1): ##STR00002## wherein R.sub.1, Ar and n are the same as defined above.
PROCESS FOR PREPARING (2Z)-2-(PHENYLIMINO)-1,3-THIAZOLIDINE-4-ONE-SULFOXIDE DERIVATIVES IN AN ENANTIOMERICALLY ENRICHED FORM
The present invention relates to a catalytic process for preparing 2-(phenylimino)-1,3-thiazolidin-4-one sulfoxide derivatives of formula (I) in enantiomerically pure or enantiomerically enriched form,
##STR00001## in which Y.sup.1, Y.sup.2, R.sup.1, R.sup.2 and R.sup.3 are as defined in the description.
Five-coordinate bis-phenylphenoxy catalysts for the preparation of ethylene-based polymers
The invention provides a molecular transition metal complex selected from Formula 1, as described herein; an ethylene-based polymer; and a process to form the ethylene-based polymer, said process comprising polymerizing ethylene in the presence of at least one molecular transition metal complex selected from Formula 1, as described herein, and wherein either Z.sub.1 or Z.sub.2 is dative covalent (coordinate) to the metal (M). ##STR00001##
METAL COMPLEXES
Embodiments of the present disclosure are directed towards metal complexes that can be utilized to form polymers. As an example, the present disclosure provides a metal complex of Formula (I) wherein M is Zr, Hf, or Ti; each Het is independently a heterocyclic; each L is independently a bridging group; each X is independently Cl, Br, I, or alkyl; each R.sup.1 is independently selected from the group including hydrogen, alkyls, alkenyls, alkynyls, cycloalkyls, aryls, acyls, aroyls, alkoxys, aryloxys, alkylthiols, dialkylamines, alkylamidos, alkoxycarbonyls, aryloxycarbonyls, carbomoyls, alkyl- and dialkyl-carbamoyls, acyloxys, acylaminos, aroylaminos, aromatic rings, fused aromatic rings, and combinations thereof; and each n is independently an integer having a value of one to five.
##STR00001##
Toluene Free Silica Supported Single-Site Metallocene Catalysts from In-Situ Supported MAO Formation in Aliphatic Solvents
The present disclosure provides a method for preparing a catalyst system comprising contacting in an aliphatic solvent at a temperature of from less than 0 C. to 60 C. at least one support material having absorbed water and at least one hydrocarbyl aluminum compound to form a supported alumoxane (catalyst precursor) and contacting the supported alumoxane with at least one catalyst compound having a Group 3 through Group 12 metal atom or lanthanide metal atom. The supported alumoxane may be heated prior to contact with the catalyst compound.
Metal organic frameworks for the catalytic detoxification of chemical warfare nerve agents
A method of using a metal organic framework (MOF) comprising a metal ion and an at least bidendate organic ligand to catalytically detoxify chemical warfare nerve agents including exposing the metal-organic-framework (MOF) to the chemical warfare nerve agent and catalytically decomposing the nerve agent with the MOF.